Some interviewed said they couldn’t be part of the pharmaceutical CEO’s trial because of his notoriety for raising the cost of a life-saving drug 5,000%

Several potential jurors at the federal securities fraud trial of Martin “Pharma Bro” Shkreli were excused on Monday after telling the judge they couldn’t be impartial toward the flamboyant former pharmaceutical CEO because of his notoriety for raising the cost of a life-saving drug 5,000%.

At jury selection in a Brooklyn courtroom, US district judge Kiyo Matsumoto questioned the potential jurors at sidebars out of earshot from Shkreli.

Continue reading…

Facebook Comments

This site uses Akismet to reduce spam. Learn how your comment data is processed.